@FierceBiotech: Analysis: 2012 life sciences VC fundraising and new bets shrivel. Article | Follow @FierceBiotech
@RyanMFierce: Eli Lilly reports positive top-line results from 2 PhIIIs of GLP1 drug, but are they positive enough to rival others? Release | Follow @RyanMFierce
> Biota Pharmaceuticals plans to ax 30% of its workforce and relocate its headquarters to Atlanta as the company shifts its focus to clinical development. Item
> LabCentral has opened shop in Cambridge, Massachusetts' Kendall Square to incubate life sciences businesses. Report
> Eli Lilly ($LLY) reports positive top-line results of two Phase III trials for its drug dulaglutide to treat type 2 diabetes. Release
> AstraZeneca ($AZN) has inked a cancer biomarker discovery pact with Oxford Cancer Biomarkers to advance research of personalized oncology drugs. Report
> Based on the minutes of its meeting with the FDA, BioCryst Pharmaceuticals ($BCRX) has confirmed that the agency would accept an NDA for peramivir for acute uncomplicated influenza. Release
Pharma News
@FiercePharma: Branded drug companies deny samples to would-be generics makers. How? REMS, partly. Article | Follow @FiercePharma
@EricPFierce: Merck starts up $120 million China packaging plant but cuts manufacturing operations elsewhere. Story | Follow @EricPFierce
> Drugmakers 'illegally' withhold samples from would-be copycats. More
> J&J pharma growth drives big increase in Q1 sales, profits. Article
> AbbVie to hack hundreds of reps from cardiovascular sales ranks. Story
@FierceMedDev: At long last, Sony and Olympus launch medical device joint venture. News | Follow @FierceMedDev
@MarkHFierce: The tech behind your old DVD player may have a second life as an HIV Dx tool. Story | Follow @MarkHFierce
@DamianFierce: JNJ CFO says company still "going through the process" of deciding whether to sell/spin off diagnostics business. | Follow @DamianFierce
> Synthes buy props up weak device sales for J&J. Report
> Panasonic to sell stake in healthcare division. Item
> Is $13.6B too steep for Life Tech? More
> Supreme Court questions validity of Myriad's gene patents. Article
Pharma Manufacturing News
> U.S. contract manufacturers kick off expansions. Article
> Hospira again names an exec to get manufacturing in order. News
> Bristol-Myers Squibb marries early-stage processes to biologics manufacturing. Article
Biotech Research News
@EmilyMFierce: Is the World's Top Neuroscience Group Quashing Dissent on the U.S. BRAIN Initiative? More | Follow @EmilyMFierce
> Scientists develop technique to rebuild brain cells destroyed by MS, cerebral palsy. Report
> Mersana's cancer drug technology cures tumors in mice at low doses. Story
> New rat model could help scientists better understand, treat Alzheimer's. Article
> Role of brain enzyme linked to neurodegeneration in mice. Item
And Finally… Sanofi ($SNY) CEO Chris Viehbacher was criticized for his comments about steering his company away from risky Alzheimer's R&D. Article